Cargando…
Decision makers need an approach to determine digital therapeutic product quality, access, and appropriate use
Autores principales: | Parcher, Benjamin, Coder, Megan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391241/ https://www.ncbi.nlm.nih.gov/pubmed/33769855 http://dx.doi.org/10.18553/jmcp.2021.27.4.536 |
Ejemplares similares
-
Best practices in designing preapproval information engagements for US health care decision makers
por: Dodda, Sai, et al.
Publicado: (2023) -
Data Empowerment of Decision-Makers in an Era of a Pandemic: Intersection of “Classic” and Artificial Intelligence in the Service of Medicine
por: Geva, Gil A, et al.
Publicado: (2021) -
Examining Tensions That Affect the Evaluation of Technology in Health Care: Considerations for System Decision Makers From the Perspective of Industry and Evaluators
por: Desveaux, Laura, et al.
Publicado: (2017) -
Appropriateness for Total Joint Replacement: Perspectives of Decision-Makers
por: Clavel, Nathalie, et al.
Publicado: (2016) -
Global accessibility of therapeutics for diabetes mellitus
por: Fralick, Michael, et al.
Publicado: (2022)